ClinicalTrials.Veeva
Menu

Find clinical trials for Lymphoma in Charlotte, NC

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

B-Cell Lymphoma
Leukemia
Non-Hodgkin Lymphoma
Lymphoid Leukemia
Diffuse Large B-Cell Lymphoma
Precursor Cell Lymphoblastic Leukemia-Lymphoma
B-Cell Chronic Lymphocytic Leukemia

Lymphoma trials near Charlotte, NC, USA:

Pediatric Classical Hodgkin Lymphoma Consortium Study: cHOD17

This is a phase II study using risk and response-adapted therapy for low, intermediate and high risk classical Hodgkin lymphoma. Chemotherap...

Enrolling
Hodgkin Lymphoma
Drug: Etoposide
Drug: DTIC

Phase 2

St. Jude Children's Research Hospital
St. Jude Children's Research Hospital

Charlotte, North Carolina, United States and 7 other locations

The purpose of this study is to evaluate the safety and pharmacokinetics of eflapegrastim in pediatric participants with solid tumors or lymphoma...

Enrolling
Lymphoma
Solid Tumors
Drug: Chemotherapy
Drug: Eflapegrastim

Phase 2

Spectrum Pharmaceuticals
Spectrum Pharmaceuticals

Charlotte, North Carolina, United States and 3 other locations

dose of BGB-11417 monotherapy for relapsed or refractory mantle cell lymphoma. Part 2 evaluates efficacy of BGB-11417 monotherapy at the rec...

Active, not recruiting
Mantle Cell Lymphoma
Relapsed Mantle Cell Lymphoma
Drug: BGB-11417

Phase 1, Phase 2

BeiGene
BeiGene

Charlotte, North Carolina, United States and 103 other locations

treatment of advanced classical Hodgkin lymphoma(HL)...

Active, not recruiting
Hodgkin Lymphoma
Drug: vinblastine
Drug: brentuximab vedotin

Phase 3

Takeda
Takeda

Charlotte, North Carolina, United States and 215 other locations

with acute lymphoblastic leukemia (ALL) and acute lymphoblastic lymphoma (LLy).Primary Therapeutic Objectives:* To improve the event-free su...

Active, not recruiting
Acute Lymphoblastic Lymphoma
Acute Lymphoblastic Leukemia
Drug: Asparaginase Erwinia chrysanthemi (recombinant)-rywn
Drug: Thioguanine

Phase 2, Phase 3

St. Jude Children's Research Hospital
St. Jude Children's Research Hospital

Charlotte, North Carolina, United States and 7 other locations

Non-Hodgkin's lymphoma (NHL) is a cancer that arises from the transformation of normal B and T lymphocytes (white blood cells). The purpose ...

Enrolling
Non-Hodgkin's Lymphoma
Drug: ABBV-291

Phase 1

AbbVie
AbbVie

Huntersville, North Carolina, United States of America and 6 other locations

in treating adults with relapsed/refractory (R/R) mantle cell lymphoma (MCL). This study will also look at the safety of sonrotoclax plus za...

Enrolling
B Cell Lymphoma
Mantle Cell Lymphoma
Drug: Sonrotoclax
Drug: Placebo

Phase 3

BeiGene
BeiGene

Charlotte, North Carolina, United States and 139 other locations

pharmacokinetic profile of GRC54276 alone and in combination with pembrolizumab or atezolizumab in participants with advanced solid tumors and lymphomas...

Active, not recruiting
Lymphoma
Advanced Solid Tumor
Drug: GRC 54276
Drug: GRC 54276 + Atezolizumab

Phase 1

Glenmark Pharmaceuticals

Huntersville, North Carolina, United States of America and 17 other locations

dose escalation and expansion clinical trial to evaluate the safety, tolerability and PK of HMPL-689 in patients with relapsed or refractory lymphomas...

Active, not recruiting
Lymphoma
Drug: HMPL-689

Phase 1

HUTCHMED
HUTCHMED

Charlotte, North Carolina, United States and 26 other locations

This is a global Phase 2, open-label, single-arm, multicohort, multicenter study to evaluate efficacy and safety of JCAR017 in adult subjects with r/...

Enrolling
Lymphoma, Non-Hodgkin
Drug: Fludarabine
Drug: JCAR017

Phase 2

Celgene
Celgene

Charlotte, North Carolina, United States and 57 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems